Biofourmis
Provides AI driven remote monitoring and digital therapeutics to manage patients at home.
What they do
Biofourmis develops platform software that uses artificial intelligence to monitor patients remotely. The platform collects physiological data from wearable devices to predict clinical decompensation, enabling early intervention by healthcare providers for conditions like heart failure.
The record
- Vertical
- Remote Monitoring & Wearables
- Sub-segment
- Remote patient monitoring
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- Boston, United States
- Region
- North America
- Founded
- 2015
- Total funding
- $330M raised
Notable investors: SoftBank Vision Fund 2, General Atlantic, CVS Health, Sequoia Capital India.